United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0832-1075_1be5841a-e872-475c-bfe9-859be4ba4001
- Product NDC
- 0832-1075
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Topiramate
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20140707
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-1075-15) · 0832-1075-15
- 1 BOTTLE in 1 CARTON (0832-1075-30) / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 0832-1075-30
- 1 BOTTLE in 1 CARTON (0832-1075-90) / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · 0832-1075-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →